Search

Samsung’s Heir Apparent Bets Big on Biotechnology Business

Samsung’s Heir Apparent Bets Big on Biotechnology Business
Samsung broke ground on a new drug manufacturing plant Monday, vowing to take a share of the growing biopharmaceutical industry by outshining rivals with speed and cost-efficiency.
Baca Berita Asal


Bagikan Berita Ini

0 Response to "Samsung’s Heir Apparent Bets Big on Biotechnology Business"

Post a Comment

Powered by Blogger.